On Invalid Date, Dariohealth (NASDAQ: DRIO) reported Q1 2023 earnings per share (EPS) of -$0.45, up 39.19% year over year. Total Dariohealth earnings for the quarter were -$12.83 million. In the same quarter last year, Dariohealth's earnings per share (EPS) was -$0.74.
As of Q2 2023, Dariohealth's earnings has grown year over year. Dariohealth's earnings in the past year totalled -$60.29 million.
What was DRIO's revenue last quarter?
On Invalid Date, Dariohealth (NASDAQ: DRIO) reported Q1 2023 revenue of $7.07 million up 12.32% year over year. In the same quarter last year, Dariohealth's revenue was $8.06 million.
What was DRIO's revenue growth in the past year?
As of Q2 2023, Dariohealth's revenue has grown 6.75% year over year. This is 0.81 percentage points higher than the US Diagnostics & Research industry revenue growth rate of 5.94%. Dariohealth's revenue in the past year totalled $26.66 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.